---
figid: PMC6883365__10.1177_1176935119889911-fig2
figtitle: Network visualization of pathways enriched with genes influencing non-platinum-based
  treatment response in oral cancer.Hexagon shapes are genes
organisms:
- NA
pmcid: PMC6883365
filename: 10.1177_1176935119889911-fig2.jpg
figlink: /pmc/articles/PMC6883365/figure/fig2-1176935119889911/
number: F2
caption: Network visualization of pathways enriched with genes influencing non-platinum-based
  treatment response in oral cancer.Hexagon shapes are genes. Dark red genes are of
  greater influence based on random forest analysis results (within top 5% of influential
  genes), white genes do not fall within the criteria of being in the top 5% of influential
  genes. All 4 common pathways enriched in patients receiving platinum and non-platinum
  therapy (described in ) were merged into one pathway using Cytoscape. Genes were
  clustered according to the Reactome Pathway Plugin available via Cytoscape. Loss
  of ring structure is indicative of differences in influence of genes between patients
  receiving platinum and non-platinum therapies.
papertitle: Identification of Targetable Pathways in Oral Cancer Patients via Random
  Forest and Chemical Informatics.
reftext: John Schomberg. Cancer Inform. 2019;18:1176935119889911.
year: '2019'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.8593072
figid_alias: PMC6883365__F2
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC6883365__F2
ndex: 1a012db4-df1a-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6883365__10.1177_1176935119889911-fig2.html
  '@type': Dataset
  description: Network visualization of pathways enriched with genes influencing non-platinum-based
    treatment response in oral cancer.Hexagon shapes are genes. Dark red genes are
    of greater influence based on random forest analysis results (within top 5% of
    influential genes), white genes do not fall within the criteria of being in the
    top 5% of influential genes. All 4 common pathways enriched in patients receiving
    platinum and non-platinum therapy (described in ) were merged into one pathway
    using Cytoscape. Genes were clustered according to the Reactome Pathway Plugin
    available via Cytoscape. Loss of ring structure is indicative of differences in
    influence of genes between patients receiving platinum and non-platinum therapies.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - GNAI2
  - WIF1
  - GBA1
  - GBA1LP
  - GNG2
  - PPIC
  - RGS9
  - RGS9BP
  - PLCG2
  - CALM1
  - CCNE1
  - ARL2
  - FYN
  - GNAZ
  - GNGT1
  - TP53
  - CHPT1
  - DHDDS
  - CPT1A
  - TRRAP
  - UHMK1
  - GNG4
  - FBXW9
  - H2AX
  - ASH2L
  - SRC
  - FGR
  - YES1
  - NFATC1
  - RGS11
  - GNB4
  - XRN2
  - GNG12
  - CCNE2
  - GNG7
  - GNB2
  - SOAT1
  - STAT1
  - STAT2
  - STAT3
  - STAT4
  - STAT6
  - STAT5A
  - STAT5B
  - GNG11
  - KRAS
  - NRAS
  - LONP2
  - SNX3
  - USP11
  - LYN
  - RAF1
  - RNASE3
  - SKIC2
  - KIFC3
  - GNAT2
  - GNG3
  - PPARD
  - SYK
  - HADH
  - HADHA
  - PAK1
  - PKN1
  - TCP1
  - MACROH2A1
  - CTNNB1
  - PYGO1
  - HDAC3
  - GNG13
  - PORCN
  - HRAS
  - PAK2
  - PKN2
  - MEN1
  - ACADL
  - GNG10
  - NT5C
  - TTR
  - TBCC
  - TBCB
  - WNT4
  - TERT
  - VPS35
  - HDAC1
  - HDAC2
  - HDAC8
  - LEO1
  - WNT3
  - PFDN2
  - VPS29
  - SOX1
  - VBP1
  - WNT2
  - SOX7
  - TUBB
  - TUBB2A
  - TUBB1
  - TUBB2B
  - TUBB3
  - TUBB4A
  - TUBB4B
  - TUBB6
  - MED17
  - MED19
  - MED22
  - MED23
  - COL9A1
  - COL9A2
  - COL9A3
  - COMP
  - SCN8A
  - CCNC
  - CDK8
  - CDK19
  - MED1
  - MED29
  - MED27
  - MED4
  - MED24
  - MED6
  - MED7
  - MED8
  - MED9
  - MED10
  - MED11
  - MED12
  - MED12L
  - MED13
  - MED13L
  - MED14
  - MED15
  - MED16
  - MED18
  - MED20
  - MED21
  - MED25
  - MED26
  - MED28
  - MED30
  - MED31
  - TLE2
  - RYK
  - PSME4
  - TRC-GCA24-1
  - APC
  - PROC
  - CTBP2
  - WNT1
  - WNT2B
  - WNT3A
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - CUL1
  - TLE4
  - PSMD3
  - EP300
  - PSMA3
  - RSPO3
  - MAFD1
  - LY86
  - CA6
  - CCNO
  - SMN1
  - GUSBP14
  - PPARA
  - CREBBP
  - FZD1
  - PSMD9
  - PSMD14
  - FZD2
  - RORA
  - DKK2
  - TLE1
  - PSMB8
  - GSK3B
  - NCOA1
  - NCOA2
  - NCOA3
  - FZD4
  - PSMC2
  - TLE5
  - MTF1
  - MELTF
  - MYT1
  - FZD5
  - RNU6-664P
  - SOX6
  - DVL3
  - PSMA1
  - UBB
  - NFYC
  - AHR
  - LGR4
  - FABP2
  - KLHL12
  - SOX2
  - SNRPN
  - DTX1
  - SRY
  - ARNT
  - MIA3
  - SIN3B
  - SMURF1
  - SMURF2
  - CUL3
  - CBY1
  - PSMD7
  - SNRPD1
  - SFRP2
  - AKT2
  - LIN9
  - RSPO1
  - TNKS
  - PPARG
  - TAB2
  - NFKBIA
  - PSMD2
  - NPAS2
  - PSMB9
  - UBC
  - RPS27A
  - XPO1
  - ARNT2
  - TAB3
  - IKBKG
  - BMAL1
  - TEAD2
  - KREMEN2
  - SOX3
  - NFYB
  - TEAD1
  - NRF1
  - NFE2L1
  - PDPK1
  - DCAF7
  - GAPDHS
  - NFATC2
  - TMED5
  - TBCD
  - ACTB
  - POTEF
  - TCF7
  - CDC7
  - LEF1
  - CD5L
  - CTAG2
  - SLC22A16
  - SLC6A10P
  - HADHB
  - PYGO2
  - CCT
  - FLVCR2
  - CCT2
  - CCT3
  - CCT4
  - CCT5
  - CCT6A
  - CCT6B
  - CCT7
  - CCT8
  - KMT2C
  - ZNHIT2
  - CHMP6
  - CRLF3
  - PSMB7
  - VPS26A
  - SOX13
  - IER3IP1
  - DKK1
  - FOLH1
  - RNF43
  - GLRX5
  - PSMB2
  - BTRC
  - HELZ2
  - KREMEN1
  - IKBKB
  - LRP6
  - ACOT12
  - CARD11
  - PFONG
  - D25 MEDI TEADI
  - HISTIHZia
  - TBCD
  - RID
  - RIHA
---
